Summary
A rare tryptamine derivative first synthesised by David Nichols. This drug, also known as lucigenol, has rarely been documented outside the lab. It is known to be a psychedelic similar to other psychoactive tryptamines, with a potency similar to DOI, but little else is known.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 750ug-1mg | 1-2mg | - | - |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Peak | Total |
|---|---|---|---|
| Oral | 15-60 min | 6.0-8.0 hrs | 360-0 min |
Tolerance
Build-up
develops rapidly after a single use
Reset
7–14 days for baseline
Cross-tolerance
Effects
Positive
- Mental/physical stimulation
- Stimulation
Negative
- Pupil dilation
- Restlessness
- Sweating/chills
- Muscle tension
- Insomnia
- Increased heart rate
- Decreased appetite
- Sedation
Positive
- Euphoria
- Empathy
- Insight
- Cognitive euphoria
- Wakefulness
Negative
- Confusion
- Anxiety
- Change in perception
- Ego softening
- Time distortion
Positive
- Brightened colour
- Enhanced tactile sensation
- Color enhancement
- Increased music appreciation
Negative
- Light sensitivity
- Appetite suppression
- Disinhibition
- Closed/Open eye visuals
- Visual distortions
- Dulled perception